These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 36064712)

  • 21. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.
    Peng H; Pan L; Ran S; Wang M; Huang S; Zhao M; Cao Z; Yao Z; Xu L; Yang Q; Lv W
    Front Endocrinol (Lausanne); 2023; 14():1083032. PubMed ID: 36742412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
    Zhang L; Zhang M; Wang M; Wang M; Zhang R; Wang H; Zhang W; Ding Y; Wang J
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):865-872. PubMed ID: 35802528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths.
    Song K; Park G; Lee HS; Lee M; Lee HI; Choi HS; Suh J; Kwon A; Kim HS; Chae HW
    J Pediatr; 2022 Mar; 242():79-85.e1. PubMed ID: 34808224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.
    Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV
    Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD.
    Dong W; Gong Y; Zhao J; Wang Y; Li B; Yang Y
    Front Endocrinol (Lausanne); 2023; 14():1281839. PubMed ID: 38260163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China.
    Xie F; Pei Y; Zhou Q; Cao D; Wang Y
    Lipids Health Dis; 2021 Oct; 20(1):132. PubMed ID: 34629056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.
    Malek M; Khamseh ME; Chehrehgosha H; Nobarani S; Alaei-Shahmiri F
    Endocrine; 2021 Dec; 74(3):538-545. PubMed ID: 34355342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
    Zeng P; Cai X; Yu X; Gong L
    Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
    He X; Huang X; Qian Y; Sun T
    Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL; Lee HK; Shin SR
    Metab Syndr Relat Disord; 2024 Jun; 22(5):402-409. PubMed ID: 38574322
    [No Abstract]   [Full Text] [Related]  

  • 32. Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children.
    Ye X; Li J; Wang H; Wu J
    Dis Markers; 2021; 2021():8833287. PubMed ID: 35059041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of anthropometric and biochemical indices in non-alcoholic fatty pancreas disease: a cross-sectional study.
    Xiao Y; Wang H; Han L; Huang Z; Lyu G; Li S
    BMJ Open; 2024 Apr; 14(4):e081131. PubMed ID: 38580356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation.
    Li X; Zhan F; Peng T; Xia Z; Li J
    Eur J Med Res; 2023 Sep; 28(1):355. PubMed ID: 37726807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.
    Zheng R; Du Z; Wang M; Mao Y; Mao W
    Lipids Health Dis; 2018 Nov; 17(1):262. PubMed ID: 30458848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between triglyceride-glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Li W; Wang Y; He F; Liu Z; Dong J; Zhang Y; Li T; Liu S; Chen E
    BMC Endocr Disord; 2022 Oct; 22(1):261. PubMed ID: 36289536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.
    Zhao J; Fan H; Wang T; Yu B; Mao S; Wang X; Zhang W; Wang L; Zhang Y; Ren Z; Liang B
    Cardiovasc Diabetol; 2022 Jul; 21(1):123. PubMed ID: 35778734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the triglyceride-glucose index with the occurrence of non-alcoholic fatty liver disease and mortality in elderly inpatients: a prospective observational study.
    Wang X; Zhou W; Song Q; Xie Y
    Nutr Hosp; 2023 Apr; 40(2):319-324. PubMed ID: 36809884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients.
    Cai Y; Chen J; Deng X; Wang B; Huang J; Lian N
    BMC Pulm Med; 2024 Jul; 24(1):359. PubMed ID: 39049008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population.
    Takahashi S; Tanaka M; Higashiura Y; Mori K; Hanawa N; Ohnishi H; Furuhashi M
    Endocr J; 2022 Apr; 69(4):463-471. PubMed ID: 34803123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.